|
55
|
130
|
5r4vA |
Xchem fragment screen -- crystal structure of the bromodomain of the human atad2 in complex with n13475a |
|
57
|
130
|
5r4xA |
Xchem fragment screen -- crystal structure of the bromodomain of the human atad2 in complex with n13413a |
|
57
|
130
|
5r4zA |
Xchem fragment screen -- crystal structure of the bromodomain of the human atad2 in complex with n13605a |
|
57
|
130
|
5r4fA |
Pandda analysis group deposition of ground-state model of atad2 |
|
57
|
130
|
5r4yA |
Xchem fragment screen -- crystal structure of the bromodomain of the human atad2 in complex with n13612a |
|
78
|
242
|
7c4jH |
Cryo-em structure of the yeast swi/snf complex in a nucleosome free state |
|
42
|
116
|
7c4iA |
High resolution structure of brpf1 bromodomain |
|
44
|
126
|
6yqpA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual inhibitor tw22 |
|
44
|
127
|
6yqoA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual inhibitor tw12 |
|
45
|
125
|
6yqnA |
Crystal structure of the first bromodomain of human brd4 in complex with the dual inhibitor tw9 |
|
43
|
110
|
6ytmA |
Human brd2(bd2) l383v mutant in complex with et-jq1-ome |
|
55
|
130
|
6yb4AAA |
Crystal structure of human atad2 bromodomain in complex with n-(4-bromo-3-(3-methylpyrrolidin-1-yl)sulfonyl)phenyl)-2-(-4-cyclopropyl-4-methyl-2,5-dioxoimidazolidin-1-yl)acetamide |
|
41
|
125
|
6xv7A |
Crystal structure of brd4-bd1 with compound 2 |
|
41
|
127
|
6xv3A |
Crystal structure of brd4-bd1 with compound 3 |
|
42
|
125
|
6xvcB |
Crystal structure of brd4-bd1 with compound 1 |
|
40
|
127
|
6xuzA |
Crystal structure of brd4-bd1 with compound 4 |
|
39
|
110
|
6viyA |
Brd2_bromodomain2 complex with pyrrolopyridone compound 27 |
|
35
|
106
|
6vizA |
Brd4_bromodomain1 complex with pyrrolopyridone compound 27 |
|
33
|
106
|
6viwA |
Brd4_bromodomain1 complex with pyrrolopyridone compound 18 |
|
41
|
107
|
6vixA |
Brd4_bromodomain2 complex with pyrrolopyridone compound 18 |
|
40
|
127
|
6p05A |
Bromodomain-containing protein 4 (brd4) bromodomain 1 (bd1) complexed with compound 27 |
|
45
|
128
|
6p3aA |
Crystal structure analysis of taf1 bromodomain |
|
52
|
128
|
6p39A |
Crystal structure analysis of taf1 bromodomain |
|
52
|
128
|
6p38A |
Crystal structure analysis of taf1 bromodomain |
|
42
|
124
|
6in2A |
Crystal structure of brd1 in complex with 18-crown-6 |
|
44
|
128
|
6in1A |
Crystal structure of the first bromodomain of brd4 in complex with 18-crown-6 |
|
24
|
121
|
1jspB |
Nmr structure of cbp bromodomain in complex with p53 peptide |
|
28
|
118
|
1jm4B |
Nmr structure of p/caf bromodomain in complex with hiv-1 tat peptide |
|
45
|
103
|
1f68A |
Nmr solution structure of the bromodomain from human gcn5 |
|
113
|
501
|
5furG |
Structure of human tfiid-iia bound to core promoter dna |
|
107
|
1048
|
6mzlA |
Human tfiid canonical state |
|
7
|
84
|
6mzdA |
Human tfiid lobe a canonical |
|
35
|
128
|
6mnlB |
Nmr solution structures of second bromodomain of brd4 with foxo3a peptide |
|
49
|
126
|
6mf9A |
Crystal structure of cgd4-650 with compound bi2536 |
|
49
|
161
|
6gytA |
Transcription factor dimerization activates the p300 acetyltransferase |
|
52
|
130
|
6epwA |
The atad2 bromodomain in complex with compound uzh-du32 |
|
56
|
130
|
6epjA |
The atad2 bromodomain in complex with compound 6 |
|
45
|
126
|
6g0pA |
Crystal structure of the first bromodomain of human brd4 in complex with an acetylated e2f1 peptide (k117ac/k120ac) |
|
52
|
130
|
6epsA |
The atad2 bromodomain in complex with compound uzh-dq41 |
|
53
|
130
|
6epxA |
The atad2 bromodomain in complex with compound 3 |
|
55
|
134
|
6df4A |
Taf1-bd2 in complex with cpd8 (6-(but-3-en-1-yl)-4-(3-(morpholine-4-carbonyl)phenyl)-1,6-dihydro-7h-pyrrolo[2,3-c]pyridin-7-one) |
|
44
|
127
|
6g0rA |
Crystal structure of the first bromodomain of human brd4 in complex with an acetylated polr2a peptide (k775ac/k778ac) |
|
45
|
125
|
6g0qA |
Crystal structure of the first bromodomain of human brd4 in complex with an acetylated gata1 peptide (k312ac/k315ac) |
|
54
|
135
|
6df7A |
Taf1-bd2 in complex with cpd27 (6-(but-3-en-1-yl)-4-(1-methyl-6-(morpholine-4-carbonyl)-1h-benzo[d]imidazol-4-yl)-1,6-dihydro-7h-pyrrolo[2,3-c]pyridin-7-one) |
|
43
|
125
|
6g0oA |
Crystal structure of the first bromodomain of human brd4 in complex with an acetylated atrx peptide (k1030ac/k1033ac) |
|
54
|
130
|
6epuA |
The atad2 bromodomain in complex with compound 2 |
|
53
|
130
|
6eptA |
The atad2 bromodomain in complex with compound 12 |
|
53
|
168
|
6gytB |
Transcription factor dimerization activates the p300 acetyltransferase |
|
41
|
127
|
6g0sA |
Crystal structure of the first bromodomain of human brd4 in complex with an acetylated sirt7 peptide (k272ac/k275ac) |
|
51
|
130
|
6epvA |
The atad2 bromodomain in complex with compound 5 |
